> GPC Biotech has signed a licensing agreement with Yakult Honsha for satraplatin in Japan. Release
> Sangamo BioSciences has presents encouraging data from a Phase I trial of its ZFP Therapeutic program. The drug is currently in two Phase II trials for the treatment of diabetic neuropathy. Release
> AstraZeneca today announced that Symbicort pressurized Metered Dose Inhaler is now available in the United States for the long-term maintenance treatment of asthma in patients 12 years of age and older. Release
> Chutes & Ladders: Acusphere CFO John Thero announced that he is leaving the company in order to "pursue other interests." Finance VP Frederick Ahlholm will fill the position until a replacement is named. Report (WSJ sub. req.)
> The FDA has approved new labeling for Genzyme's cartilage repair drug Carticel based on the completion of a post-approval commitment study. Release
And Finally... A new report predicts that China's Pharmaceutical market will become the fifth largest by 2010 and the world's largest by 2050. However, there are a number of hurdles the country must overcome before it can take its place as a leader in the pharmaceutical industry. Release